Substrate recognition by P-glycoprotein and the multidrug resistance- associated protein MRP1: A comparison

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 3, 2000, Pages 111-121

  Seelig, A ^a   Li Blatter, X ^a   Wohnsland, F ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

(MRP1); Associated protein; Hydrogen bonds; Multidrug resistance; P glycoprotein (P gp); Substrate recognition; Substrate specificity

Indexed keywords

2,4 DINITROPHENOL; BILIRUBIN GLUCURONIDE; CHEMICAL COMPOUND; CHLORAMBUCIL; DAUNORUBICIN; DOXORUBICIN; ESTRADIOL DERIVATIVE; FLUNITRAZEPAM; GLUTATHIONE; GLYCOPROTEIN P; HYODEOXYCHOLIC ACID; LEUKOTRIENE C4; MALEIC ACID; MULTIDRUG RESISTANCE PROTEIN; NIFEDIPINE; PROBENECID; PROSTAGLANDIN A1; SULFINPYRAZONE; VANADATE SODIUM;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HYDROGEN BOND; MEMBRANE TRANSPORT; MOLECULAR RECOGNITION; PROTEIN DOMAIN;

EID: 0034055630     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38111     Document Type: Article

References (37)

1. Bakos E, Evers R, Szakacs G, Tusnady GE, Welker E, Szabo K, de Haas M, van Deemter L, Borst P, Varadi A, Sarkadi B 1998 Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem 273: 32167-32175
2. Bakos E, Hegedus T, Rollo Z, Welker E, Tusnady GE, Zaman GJ, Flens MJ, Paradi A, Sarkadi B 1996 Membrane topology and glycosylation of the human multidrug resistance-associated protein. J Biol Chem 271: 12322-12326
3. Barnouin K, Leier I, Jedlitschky G, Pourtier-Manzanedo A. König J, Lehmann WD, Keppler D 1998 Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. Br J Cancer 77: 201-209
4. Bartosz G, König J, Keppler D, Hagmann W 1998 Human mast cells secreting leukotriene C4 express the MRP1 gene-encoded conjugate export pump. Biol Chem 379: 1121-1126
5. Beck WT, Cirtain MC, Glover CJ, Felsted RL, Safa AR 1988 Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine. Biochem Biophys Res Commun 153: 959-966
6. Borst P, Kool M, Evers R 1997 Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? Semin Cancer Biol 8: 205-213
7. Burkert U, A Alinger NL 1982 Molecular Mechanics, ACS Monograph 177. American Chemical Society, Washington, DC
8. Chattopadhyay A 1990 Chemistry and biology of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipids: fluorescent probes of biological and model membranes. Chem Phys Lipids 53: 1-15
9. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EV, Duncan AM, Deeley RG 1992 Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
10. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler A, Melamed MR, Bertino A 1989 Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695-698
11. Dekkers DW, Comfurius P, Schroit AJ, Bevers EM, Zwaal RF 1998 Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37: 14833-14837
12. Devaux PF 1992 Protein involvement in transmembrane lipid asymmetry. Annu Rev Biophys Biomol Struct 21: 417-439
13. Evers R, Cnubben NH, Wijnholds J, van Deemter L, van Bladeren PJ, Borst P 1997 Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett 419: 112-116
14. Fischer H, Gottschlich R. Seelig A 1998 Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol 165: 201-211
15. Gottesman MM, Pastan I 1993 Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427
16. Cros P, Croop J, Housman D 1986 Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380
17. Higgins CF, Gottesman MM 1992 Is the multidrug transporter a flippase? Trends Biochem Sci 17: 18-21
18. Hipfner DR, Almquist KC, Leslie EM, Gerlach JH, Grant CE, Deeley RG, Cole SP 1997 Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus. J Biol Chem 272: 23623-23630
19. Jedlitschky G, Leier I, Buchholz U, Hummel-Eisenbeiss J, Burchell B, Keppler D 1997 ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepalocyte canalicular isoform MRP2. Biochem J 327: 305-310
20. Kast C, Gros P 1998 Epitope insertion favors a six-transmembrane domain model for the carboxy-terminal portion of the multidrug resistance-associated protein. Biochemistry 37: 2305-2313
21. Keppler D, Leier I, Jedlitschky G 1997 Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378: 787-791
22. Piekarz RL, Cohen D, Horwitz SB 1993 Progesterone regulates the murine multidrug resistance mdr1b gene. J Biol Chem 268: 7613-7616
23. Priebe W, Krawczyk M, Kuo MT, Yamane Y, Savaraj N, Ishikawa T 1998 Doxorubicin-and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun 247: 859-863
24. Raggers RJ, van Helvoort A, Evers R, van Meer G 1999 The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J Cell Sci 112: 415-422
25. Rebbeor JF, Connolly GC, Dumont ME, Ballatori N 1998 ATP-dependent transport of reduced glutathione on YCR. the yeast orthologue of mammalian multidrug resistance-associated proteins. J Biol Chem 273: 33449-33454
26. Rebbeor JF, Senior AE 1998 Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form. Biochim Biophys Acta 1369: 85-93
27. Schiffer M, Edmundson AB 1967 Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J 7: 121-135
28. Schinkel AH, Wagenaar E, Mol CA, van Deemter L 1996 P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97: 2517-2524
29. Schuetz EC, Beck WT, Schuetz JD 1996 Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinated up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49: 311-318
30. Seelig A 1998 A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 251: 252-261
31. Sokal A, Bartosz G 1998 Uncouplers of mitochondrial oxidative phosphorylation are not substrates of the erythrocyte glutathione-S-conjugate pump. Arch Biochem Biophys 349: 113-121
32. Su GM, Davey MW, Davey RA 1998 Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel. Int J Cancer 76: 702-708
33. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC 1987 Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738
34. van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G 1996 MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507-517
35. Vinogradov SN, Linell RH 1971 Hydrogen Bonding. Van Nostrand Reinhold, New York
36. Zhang X, Collins KI, Greenberger LM 1995 Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1. J Biol Chem 270: 5441-5448
37. Zhong W, Gallivan JP, Zhang Y, Li L, Lester HA, Dougherty DA 1998 From ab initio quantum mechanics to molecular neurobiology: a cation-pi binding site in the nicotinic receptor. Proc Natl Acad Sci USA 95: 12088-12093